We show that neurological features are not a major characteristic of these patients and describe novel clinical findings of anemia, hyperferritinemia, and cholestasis as prominent early features, thereby expanding the spectrum of extrapancreatic features associated with PTF1A distal enhancer mutations. The gene discussed is PTF1A; the disease is isolated hyperferritinemia.